Chief Financial Officer Jens Holstein says BioNTech expects to recognize about 90% of its full-year revenue in the last months of 2024, mostly in the fourth quarter. "With a strong cash position ...
9 hours ago
Investing.com
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
8 hours ago
Motley Fool via Yahoo
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
11 hours ago
Benzinga via Yahoo
What's Going With BioNTech Stock On Monday?
13 hours ago
Morningstar Research via Yahoo
Analyst Report: BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including ...
Barrons.com
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
18 hours ago
RTT News
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
German Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply lower net revenues ...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Zacks via Yahoo
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
7 days ago
View all
Biotechnology company from Germany
biontech.com
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Wikipedia
More on Yahoo Finance